News | September 09, 2009

Abiomed Showcases Impella Technology at TCT 2009

September 9, 2009 – Abiomed Inc. said today its percutaneous Impella ventricular assist device will be highlighted in several clinical sessions at the upcoming TCT 2009 scientific meeting Sept. 21-25, in San Francisco.

Abiomed will also conduct daily booth demonstrations at Abiomed booth 1230 and hands-on simulations of its heart recovery platforms. The company will also broadcast daily live feeds of Impella cases from the TCT line-up of live case broadcasts. In addition, the Abiomed booth will feature physicians presenting challenging cases using Impella 2.5.

On Monday, Sept. 21 the company will host “Device-Based Approaches for Heart Failure: Recent Developments and New Directions?Session V: Acute Hemodynamic Support Devices” in room 132 at the Moscone Convention Center. Sessions involving the Impella are at:
• 2:50 – 3:02 p.m. “Circulatory Support in STEMI: Intra-aortic Balloon Counterpulsation vs. Impella,” presented by Jose P.S. Henriques, M.D., Ph.D., Academic Medical Center, University of Amsterdam
• 3:02 – 3:14 p.m. – “The Impella 5.0 Device: Surgical and Cardiogenic Shock Applications,” presented by Anson Cheung, M.D. clinical associate professor, surgical director, cardiac transplant program of BC Active Staff, St. Paul's Hospital Vancouver
• 3:14 – 3:26 p.m. – “Results from USpella, the first registry presentation on the U.S. commercial Impella experience with over 100 patients,” presented by Brijeshwar Maini, M.D., cochair, cardiovascular research, interventional cardiologist, Pinnacle Health; attending cardiologist, Moffitt Heart & Vascular Group
• 3:26 – 3:38 p.m. – “Continuum in Circulatory Support to Recover the Failing Heart: How and When to Escalate from Percutaneous to Surgical VADs,” presented by Mark Anderson, M.D., associate professor of surgery at UMDNJ-Robert Wood Johnson Medical School and chief of the section of cardiac surgery at Robert Wood Johnson University Hospital

On Tuesday, Sept. 22 Abiomed will host an investor and analyst meeting from 4-5 p.m. in 22?room Golden Gate 4, Hilton San Francisco. The meeting will provide a 40-minute overview and update on Impella progress, followed by a 20-minute forum for questions and open discussion. To register, contact Aimee Maillett at [email protected] or (978) 646-1553.

Abiomed will host an evening symposium – “Hemodynamic Principles to Patient Application”?– Tuesday, Sept. 22, in the Imperial Ballroom, Hilton San Francisco. There is a cocktail reception from 7-8 p.m., followed by the symposium from 8-10 p.m. It is chaired by William O’Neill, M.D., executive dean for clinical affairs at the University of Miami. This is a customer event and participation for noncustomers is subject to availability and Abiomed discretion. Noncustomers must request attendance by contacting Aimee Maillett at [email protected] or (978) 646-1553. Speakers include: John Lasala, M.D., Ph.D., medical director of the cardiac cath lab, associate professor of medicine and director of interventional cardiology at Barnes-Jewish Hospital; Samin Sharma, M.D., director of the cath lab and interventions, Mount Sinai Medical Center; Jose P.S. Henriques, M.D., Ph.D., Academic Medical Center, University of Amsterdam.

On Wednesday, Sept. 23 is a breakfast session, “Impella 2.5 - Case Reviews of Real World Application,” in 23?room 114 A, Moscone Convention Center. Breakfast is?6:30–7 a.m. and the session is from 7–8 a.m. It is chaired by Charanjit S. Rihal, M.D., director of the cardiac cath lab and professor of medicine, Mayo Clinic.

Another breakfast session, “Impella 2.5 - Hemodynamic Support in High Risk PCI and Cardiogenic Shock: A Case-Based Review”? will be held Friday, Sept. 25 in?room 114, Moscone Convention Center. ?It will focus on a new fellow scholarship program where fellows present their best Impella cases to their peers, called, “International Fellows Awarded Best Impella Case of the Year,” chaired by Roxana Mehran, M.D., director of outcomes research, data coordination and analysis, associate professor of medicine, New York-Presbyterian Hospital/Columbia University Medical Center and director of clinical research, data coordination and analysis center at the Cardiovascular Research Foundation.

For additional information:

Related Content

Sponsored Content | Videos | Cardiovascular Ultrasound| July 19, 2017
This video educational session, provided in partnership with the American Society of Echocardiography (ASE), is title
Pre-PCI Impella 2.5 Insertion Improves Survival in Left Main Coronary Artery Heart Attacks
News | Ventricular Assist Devices (VAD)| June 30, 2017
Abiomed Inc. announced the recent publication of a peer-reviewed retrospective study on hemodynamic support with the...
Italian Boy Becomes Youngest Patient Bridged to Transplant With SynCardia Total Artificial Heart

Andrei, 12, is the world’s youngest patient to be bridged to transplant with the SynCardia Total Artificial Heart. He is pictured after his heart transplant with his surgeon, Antonio Amodeo, M.D., at Bambino Gesù Children’s Hospital in Rome, Italy. Photo courtesy of Business Wire.

News | Congenital Heart| June 22, 2017
A 12-year-old boy at Bambino Gesù Children’s Hospital in Rome, Italy, has become the world’s youngest patient to be...
Abiomed Impella CP pVAD, third-generation CP
Technology | Hemodynamic Support Devices| June 12, 2017
June 12, 2017 — Abiomed Inc.
tandemLife Tandemheart priming tray cleared by FDA
Technology | Hemodynamic Support Devices| June 12, 2017
June 12, 2017 — TandemLife began its commercial launch of the TandemLife Priming Tray, a new product designed to simp
Sponsored Content | Videos | Cardiovascular Ultrasound| May 26, 2017
This video, provided in partnership with the American Society of Echocardiography (ASE), is titled "Intraoperative Tr
Impella CP study to investigate door to left ventricular unloading time
News | May 09, 2017
May 9, 2017 — The first patient has been enrolled in the U.S.
Heartware HVAD recall for its ventricular assist device from Medtronic
Feature | Ventricular Assist Devices (VAD)| May 05, 2017
May 5, 2017 — Medtronic Mechanical Circulatory Support is expanding its recall of its HeartWare Ventricular Assist De
the Impella pVAD improves survival, mortality in AMI heart attack with cardiogenic shock

Early use of the Impella percutaneous ventricular assist device prior to angioplasty may significantly improve survival for patients in cardiogenic shock.

Feature | Hemodynamic Support Devices| April 28, 2017 | Dave Fornell
Recent clinical study data presented at the American College of Cardiology (ACC) 2017 meeting show new treatment prot
Sponsored Content | Videos | Ventricular Assist Devices (VAD)| April 14, 2017
A discussion with William O'Neill, M.D., FACC, FSCAI, medical director of the Center for Structural Heart Disease at
Overlay Init